Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab
出版年份 2019 全文链接
标题
Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab
作者
关键词
-
出版物
INTENSIVE CARE MEDICINE
Volume 45, Issue 10, Pages 1360-1371
出版商
Springer Science and Business Media LLC
发表日期
2019-10-02
DOI
10.1007/s00134-019-05704-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immune Checkpoint Inhibition in Sepsis
- (2019) Richard S. Hotchkiss et al. CRITICAL CARE MEDICINE
- Novel Interventions
- (2018) Jean-Louis Vincent et al. CRITICAL CARE CLINICS
- Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial
- (2018) Philippe Armand et al. JOURNAL OF CLINICAL ONCOLOGY
- Evidence for Persistent Immune Suppression in Patients Who Develop Chronic Critical Illness After Sepsis
- (2018) Julie A. Stortz et al. SHOCK
- Association between mRNA expression of CD74 and IL10 and risk of ICU-acquired infections: a multicenter cohort study
- (2017) Estelle Peronnet et al. INTENSIVE CARE MEDICINE
- Prognostic Accuracy of the SOFA Score, SIRS Criteria, and qSOFA Score for In-Hospital Mortality Among Adults With Suspected Infection Admitted to the Intensive Care Unit
- (2017) Eamon P. Raith et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014
- (2017) Chanu Rhee et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Nivolumab plus interferon-γ in the treatment of intractable mucormycosis
- (2017) David Grimaldi et al. LANCET INFECTIOUS DISEASES
- Advances in the understanding and treatment of sepsis-induced immunosuppression
- (2017) Fabienne Venet et al. Nature Reviews Nephrology
- Cytokine storm and sepsis disease pathogenesis
- (2017) Benjamin G. Chousterman et al. Seminars in Immunopathology
- Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations
- (2016) Carolin Fleischmann et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1
- (2016) Andriani C. Patera et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study
- (2016) Emma E Davenport et al. Lancet Respiratory Medicine
- Up-regulation of Programmed Cell Death 1 Ligand 1 on Neutrophils May Be Involved in Sepsis-induced Immunosuppression
- (2015) Jia-Feng Wang et al. ANESTHESIOLOGY
- Persistent lymphopenia is an independent predictor of mortality in critically ill emergency general surgical patients
- (2015) P. E. Vulliamy et al. European Journal of Trauma and Emergency Surgery
- Timing and causes of death in septic shock
- (2015) Fabrice Daviaud et al. Annals of Intensive Care
- Hospital Deaths in Patients With Sepsis From 2 Independent Cohorts
- (2014) Vincent Liu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Persistent Lymphopenia After Diagnosis of Sepsis Predicts Mortality
- (2014) Anne M. Drewry et al. SHOCK
- Why have clinical trials in sepsis failed?
- (2014) John C. Marshall TRENDS IN MOLECULAR MEDICINE
- Reduction of Immunocompetent T Cells Followed by Prolonged Lymphopenia in Severe Sepsis in the Elderly*
- (2013) Shigeaki Inoue et al. CRITICAL CARE MEDICINE
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inter-laboratory assessment of flow cytometric monocyte HLA-DR expression in clinical samples
- (2012) Julie Demaret et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Into the Eye of the Cytokine Storm
- (2012) J. R. Tisoncik et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
- (2011) Jonathan S. Boomer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis
- (2010) P. Brahmamdam et al. JOURNAL OF LEUKOCYTE BIOLOGY
- PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis
- (2009) X. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started